RecruitingNot ApplicableNCT06989892

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial


Sponsor

Navamindradhiraj University

Enrollment

202 participants

Start Date

Jul 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml)

Exclusion Criteria2

  • Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.
  • Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.

Interventions

DEVICESuper High-flux dialyzer (Elisio 19HDx)

Dialysis with Super High-flux dialyzer for intervention group

DEVICEHigh-flux dialyzer (Elisio 19H)

Dialysis with High-flux dialyzer for control group


Locations(1)

Navamindhradhiraj university

Dusit, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06989892


Related Trials